Weaver Lindell K, Chhoeu Austin, Lindblad Anne S, Churchill Susan, Deru Kayla, Wilson Steffanie H
Division of Hyperbaric Medicine Intermountain Medical Center, Murray, Utah, and Intermountain LDS Hospital, Salt Lake City, Utah U.S.
University of Utah School of Medicine, Salt Lake City, Utah U.S.
Undersea Hyperb Med. 2016 Aug-Sept;43(5):485-489.
The Brain Injury and Mechanism of Action of Hyperbaric Oxygen for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury (mTBI) (BIMA) study, sponsored by the Department of Defense and held under an investigational new drug application by the Office of the Army Surgeon General, is one of the largest and most complex clinical trials of hyperbaric oxygen (HBO₂) for post-concussive symptoms (PCS) in U.S. military service members.
由国防部资助、在陆军军医局局长办公室的新药临床试验申请下开展的“轻度创伤性脑损伤（mTBI）后持续性脑震荡后症状的脑损伤与高压氧作用机制（BIMA）研究”，是美国现役军人中针对脑震荡后症状（PCS）开展的最大型、最复杂的高压氧（HBO₂）临床试验之一。
